| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/14/1997 | US5593696 Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders |
| 01/14/1997 | US5593665 Pharmaceutical compositions |
| 01/14/1997 | CA2053880C Treatment of motility disorders with a gnrh analog |
| 01/14/1997 | CA1338845C Thiophene 2-carboxamide derivatives and their use as pharmaceuticals |
| 01/14/1997 | CA1338844C Thiophene carboxamine derivatives and their use as pharmaceuticals |
| 01/09/1997 | WO1997000698A1 Inhibition of hepatitis b replication |
| 01/09/1997 | WO1997000688A1 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders |
| 01/09/1997 | WO1997000680A1 Use of n-cyclohexyl benzamides for treating bowel disorders |
| 01/09/1997 | WO1997000677A1 Use of ubenimex and the pharmaceutical composition containing it for treating virus hepatitis |
| 01/09/1997 | CA2224477A1 Inhibition of hepatitis b replication |
| 01/09/1997 | CA2221863A1 New therapeutic applications of n-cyclohexylbenzamides |
| 01/09/1997 | CA2219739A1 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders |
| 01/08/1997 | EP0752246A2 Kappa opiate agonists for inflammatory gut diseases |
| 01/08/1997 | EP0751949A1 Anti-hepatitis b viral oligonucleotides |
| 01/08/1997 | EP0751936A1 New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor |
| 01/08/1997 | EP0751772A1 New use of quinoline-3-carboxamide compounds |
| 01/08/1997 | EP0751770A1 8-substituted tetrahydro-beta-carbolines |
| 01/08/1997 | EP0668863B1 Quinuclidine derivative as substance p antagonist |
| 01/08/1997 | EP0583244B1 Method of producing zero-order controlled-release devices |
| 01/08/1997 | EP0469075B1 Use of lipoxin a 4? and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 01/08/1997 | CN1139932A N-terminally chemically modified protein compositions and methods |
| 01/08/1997 | CN1139928A Novel compound |
| 01/08/1997 | CN1139927A Substituted morpholine derivatives and their use as therapeutic agents |
| 01/08/1997 | CN1139880A Diphenyl-2-propenoates and homologs thereof useful for threating diseases associated with leukotriene B4 |
| 01/08/1997 | CN1139666A Novel tricyclic amide, its preparation method and medicinal combination |
| 01/07/1997 | US5591775 Sleep disorders |
| 01/07/1997 | US5591761 Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/07/1997 | US5591754 Benzoylguanidines, pharmaceutical composition containing them and treatment of arrthythmias therewith |
| 01/07/1997 | US5591743 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives as 5HT1A ligands |
| 01/07/1997 | CA2029050C Sustained release compositions for treating periodontal disease |
| 01/03/1997 | WO1997000088A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 01/03/1997 | WO1997000070A1 Novel medical use |
| 01/03/1997 | CA2225175A1 Novel medical use |
| 01/03/1997 | CA2224697A1 Rotavirus enterotoxin nsp4 and methods of using same |
| 01/02/1997 | EP0751137A1 Oxaindene derivatives and a process for preparing them as well as medicaments containing them and the use of them |
| 01/02/1997 | EP0750666A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
| 01/02/1997 | EP0750635A1 Peptides inhibiting the release of pepsine |
| 01/02/1997 | EP0750631A1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 01/02/1997 | EP0750617A1 Novel heterocyclic ethanolamine derivatives with beta-adrenoreceptor agonistic activity |
| 01/02/1997 | EP0750511A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor |
| 01/01/1997 | CN1139435A New ginkgolide derivatives and process for preparing them |
| 01/01/1997 | CN1139434A Diazabicyclic neurokinin antagonists |
| 01/01/1997 | CN1139430A Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 01/01/1997 | CN1139383A Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 12/31/1996 | US5589501 Pharmaceutical compounds |
| 12/31/1996 | US5589496 Fused benzeneoxyacetic acid derivatives which have PGI2 receptor agonist activity |
| 12/31/1996 | US5589491 Injection and injection kit containing omeprazole and its analogs |
| 12/31/1996 | US5589484 Treatment of helicobacter infections, antiulcer |
| 12/31/1996 | US5589476 Imidazol-4-ylpiperidine derivatives, their preparation and their application in therapeutics |
| 12/31/1996 | US5589358 Ileal bile acid transporter compositions and methods |
| 12/31/1996 | US5589168 Strain of enterococcus useful for treatment and prevention of irritable bowel syndrome |
| 12/31/1996 | US5589047 Using dielectrophoresis for genetic engineering |
| 12/28/1996 | CA2180029A1 Oxaindene derivatives and process for the preparation thereof |
| 12/27/1996 | WO1996041795A1 Benzamide derivatives and their use as vasopressin antagonists |
| 12/27/1996 | WO1996041645A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | WO1996041643A1 Antiviral method and antiviral agent |
| 12/27/1996 | WO1996041626A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | WO1996041625A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 12/27/1996 | WO1996021731A3 Stabilized external guide sequences |
| 12/27/1996 | EP0749964A1 N-Heterocyclyl biphenyl sulfonamides |
| 12/27/1996 | EP0749442A1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 12/27/1996 | EP0749422A1 Indole derivatives as cck receptor antagonists |
| 12/27/1996 | EP0749322A1 VACUOLATING TOXIN-DEFICIENT $i(H. PYLORI) AND RELATED METHODS |
| 12/27/1996 | EP0749314A1 Method for treating and inhibiting gastric and duodenal ulcers |
| 12/27/1996 | EP0749313A1 Method for treating 5ht 2b receptor related conditions |
| 12/27/1996 | EP0749308A1 Film coated tablet of paracetamol and domperidone |
| 12/27/1996 | EP0749306A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 12/27/1996 | EP0749302A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof |
| 12/27/1996 | CA2224563A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | CA2224517A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | CA2224379A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 12/27/1996 | CA2223869A1 Benzamide derivatives and their use as vasopressin antagonists |
| 12/25/1996 | CN1138853A 1,5-benzodiazepine derivatives useful as CCK or gastrin antagonists |
| 12/25/1996 | CN1138851A Metalloproteinase inhibitors |
| 12/25/1996 | CN1138572A Application of Ubimec medicinal compsn. or containing ubimec for treatment virus hepatitis |
| 12/25/1996 | CN1033646C 4,13-dioxy-bicyclo(8,2,1)tridecylenone derivative, its prepn. method and its intermediate product and said compound-contained medicament |
| 12/24/1996 | US5587480 Treating hiv and hepatitis virus infections |
| 12/24/1996 | US5587479 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 12/24/1996 | US5587376 Antiischemic agents, decongestants |
| 12/19/1996 | WO1996040954A1 Oral delivery of adeno-associated viral vectors |
| 12/19/1996 | WO1996040872A1 Bile duct progenitor cells and methods of use |
| 12/19/1996 | WO1996040865A1 Replacement therapy for dental caries |
| 12/19/1996 | WO1996040737A1 Reversible cysteine protease inhibitors |
| 12/19/1996 | WO1996040681A1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 12/19/1996 | WO1996040672A1 Combinatorial libraries having aminodiol monomer subunits |
| 12/19/1996 | WO1996040660A1 Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands |
| 12/19/1996 | WO1996040647A1 α-(1,3-DICARBONYLENOL ETHER) METHYL KETONES AS CYSTEINE PROTEASE INHIBITORS |
| 12/19/1996 | WO1996040638A1 Heteroaryl diol acids as leukotriene antagonists |
| 12/19/1996 | WO1996040224A1 Regulation of cytokine synthesis and release |
| 12/19/1996 | WO1996040184A1 New cryptophycins from synthesis |
| 12/19/1996 | WO1996040168A2 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 12/19/1996 | WO1996040164A1 Nucleosides with anti-hepatitis b virus activity |
| 12/19/1996 | WO1996040134A1 Calcium channel antagonists |
| 12/19/1996 | WO1996040133A1 Optically pure (-) norcisapride for treating digestive tract disorders |
| 12/19/1996 | WO1996040116A1 Indolinone compounds for the treatment of disease |
| 12/19/1996 | WO1996040104A1 Hydroxyl ions as unique therapeutic agents and compounds that modulate ions, compounds |
| 12/19/1996 | WO1996040081A2 Oral delivery of gene constructs |
| 12/19/1996 | WO1996040078A1 Delivery of drugs to the lower gi tract |
| 12/19/1996 | WO1996040050A1 Oral dosage and method for treating painful conditions of the oral cavity |
| 12/19/1996 | CA2224170A1 Delivery of drugs to the lower gi tract |